Zdenek Vrozina Profile picture
Feb 13 10 tweets 2 min read Read on X
A new macaque study looked at how immune memory forms after infections with different SARS-CoV-2 variants.
The main pattern is familiar from other viruses -
immune imprinting tends to stay biased toward earlier variants, even after later infections.🧵
The model is useful because it allows sequential infections under controlled conditions (Wuhan - Delta - Omicron), something that’s hard to observe clearly in humans.
Omicron as a primary infection = relatively weak new immune imprint
After first Omicron infection in macaques -
variant-specific anti-Omicron RBD antibodies developed slowly
overall immunogenicity was lower
T-cell responses were also weaker.
This suggests that a single Omicron infection may not generate particularly strong variant specific protection against reinfection with similar strains.
Prior infection with earlier variants = persistent imprinting
When animals had previous exposure (eg Delta or earlier strains), later infections - including Omicron - tended to boost antibodies targeting Wuhan-like epitopes more strongly than Omicron-specific ones.
This pattern reflects what immunology describes as
original antigenic sin (immune imprinting) -
where the first strong antigenic exposure continues to shape responses to later variants.
So even after reinfection with a different variant, the immune system often recalls and amplifies earlier memory responses rather than fully shifting toward new variant-specific targets.
Imprinting here is not specific to Delta.
It reflects the effect of the first strong antigenic exposure - whether that was Wuhan, Alpha, or Delta.
Delta simply represents the last highly immunogenic preOmicron variant in this dataset.
Sum:
In this model -
Primary Omicron infection - relatively weak variant-specific imprinting
Earlier variant exposure - lasting immune bias toward ancestral epitopes during later infections.
Urano at al., Pathological characteristics of SARS-CoV-2 variants and immune responses induced in a COVID-19 macaque model. nature.com/articles/s4200…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Zdenek Vrozina

Zdenek Vrozina Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ZdenekVrozina

Feb 12
A new study in Neuron links nuclear pore breakdown to TDP-43 pathology in ALS and related dementias.
This pathway is especially relevant because SARS-CoV-2 can both cleave TDP-43 and disrupt nuclear transport - potentially hitting the same vulnerability from two directions.🧵
The nuclear pore is a critical cellular gate.
It regulates the movement of RNA and proteins between the nucleus and cytoplasm.
In ALS and some dementias, this gate is known to fail - and TDP-43 leaves the nucleus and accumulates in toxic aggregates.
But why the pore breaks down has been unclear.
The study identifies a key player - VCP.
Normally, it acts as a cellular cleanup system, removing damaged proteins.
The problem arises when it becomes overactive.
Read 16 tweets
Feb 11
A new study in Frontiers in Medicine analyzed 959 hospitalized COVID-19 patients (pre-vaccination).
It shows that T cell counts at admission strongly predict severe outcomes and mortality.
This isn’t just about inflammation - adaptive immunity is central🧵
Patients with CD3 T cells ≤ 666/mm³ had
2.3× higher risk of needing ventilatory support
2.4× higher risk of in-hospital death
CD4 ≤ 359/mm³ was associated with
2.8× higher risk of death
These associations remained independent after adjustment.
The study supports a model in which
T-cell responses (especially CD3/CD4) are weakened
Adaptive immunity fails to adequately control the virus
The body compensates through hyperactivation of innate immunity
The result is severe disease
Read 5 tweets
Feb 8
This study suggests that in some patients, COVID-19 triggers a long-term process of vascular and cardiac injury that can gradually increase pulmonary pressure, strain the right ventricle, and raise the risk of death in the following years🧵
The study followed 480 hospitalized patients (240 moderate, 240 severe) for one year after discharge. It assessed heart function using echocardiography and measured biomarkers of vascular inflammation.
In severe COVID-19, right-ventricular function was already significantly worse at the first study examination. Over the following year, pulmonary artery pressure increased by 17.8% in severe cases and 7.1% in moderate cases!
Read 14 tweets
Feb 6
If normal population plasma truly carries more low-grade inflammation, this study hints at a fork in the road.
Either we lower the bar and call it a new normal,
or this is a hidden population burden that will surface later as comorbidities🧵
A new study on the cytokine IL-32 after COVID-19 points directly at this uncomfortable question.
The authors analyzed nearly 1,000 healthy blood donors sampled before and during the pandemic, plus 212 hospitalized COVID-19 patients.
The result is consistent - plasma collected after 2020 shows systematically higher IL-32 levels compared to pre-pandemic plasma.
Read 9 tweets
Feb 6
Neurocognitive Long COVID doesn’t disappear.
Not with Omicron.
Not in a highly vaccinated population.
Even when most other organ-level signals fade🧵
A new population-level study from Singapore looked at 1.4 million COVID cases in a setting with >90% booster coverage.
Result - multi-organ Long COVID largely attenuates.
But the brain remains an exception.
The study tracked new medical diagnoses 31–300 days after infection across Delta and multiple Omicron waves (BA.1/2, BA.4/5, XBB).
Across variants, most organ systems normalize.
Neurocognitive diagnoses do not.
Read 10 tweets
Feb 5
This study does not tell us what exactly causes long COVID or ME/CFS, nor does it test clinical symptoms like PEM.
But it may tell us something just as important - what type of biological problem this likely is..🧵
The authors isolated immunoglobulins (IgG) from people with post-infectious ME/CFS, including post-COVID ME/CFS, and tested what these antibodies do to healthy cells.
In a subset of patients, these IgG alter the behavior of endothelial cells and their mitochondria.
Not by killing the cells or shutting down ATP production.
Read 17 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(